The Prof G Pod with Scott Galloway Prof G Markets: Scott’s NJOY Stake, the JetBlue/Spirit Merger, and WeightWatchers Buys Ozempic Maker
5 snips
Mar 13, 2023 
In this insightful discussion, guest Ed Elson, a Prof G media analyst, joins Scott to dissect significant market movements. They highlight Scott's early investment in NJOY, which promises an astonishing 30x return after Altria's acquisition. The duo debates the merits and pitfalls of the JetBlue/Spirit merger, considering antitrust concerns. They also explore WeightWatchers’ bold entry into the weight loss drug market, reflecting on broader societal impacts and the evolving landscape of corporate America.
AI Snips
Chapters
Books
Transcript
Episode notes
NJOY Investment
- Scott Galloway invested $2.5 million in NJOY in 2017, partially due to personal experiences with tobacco's impact.
- His mother's death from smoking motivated his involvement in a smoking cessation product.
Unexpected Success and Lingering Anxiety
- Scott Galloway's NJOY investment is projected to return $60-80 million, a 30x return.
- Despite financial success, he still experiences financial anxiety and insecurity.
Investment Basics
- Diversify investments and avoid putting all your capital into one venture, as market outcomes are unpredictable.
- Patience and a long-term outlook are crucial for investment success.
